Takeda Jumps After Winning FDA Approval for Diabetes Drug

Takeda Pharmaceutical Co., whose best-selling diabetes drug Actos lost patent protection in August, rose to the highest level in more than four years after winning U.S. regulatory approval for a new treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.